Skip to content

Maximus

US · MMS #2545 by market cap Listed 1970
55.65 +0.97 +1.77%
Live - 5344 symbols - heartbeat 403s ago · 2026-10-07 20:02
After-hours 56.00 +0.63%
Market cap
2.91B
P/B
1.67
EPS
5.51
Reader sentiment Are you bullish or bearish on MMS?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.4 percentage points.

Institutional ownership

Held by institutions
108.33% -0.37pp
Institutions
422 -2
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund92.75%
Hedge Fund7.77%
Public Company3.24%
Government Pension Fund1.98%
Individual/Insider1.44%
Sovereign Wealth Fund1.43%
Private Company0.78%
Insurance Company0.20%
Family Office/Trust0.14%

Top holders as of 2026-06-30

BlackRock 14.22% · 7.44M sh
FMR 8.83% · 4.62M sh
Vanguard Portfolio Management, LLC 6.47% · 3.39M sh
Vanguard Capital Management, LLC 5.20% · 2.72M sh
Fuller & Thaler Asset Management, Inc. 5.16% · 2.70M sh
State Street Global Advisors 4.90% · 2.57M sh
Dimensional Fund Advisors 4.50% · 2.35M sh
Reinhart Partners, LLC 3.79% · 1.98M sh
Geode Capital Management, LLC 3.01% · 1.58M sh
Van Berkom and Associates Inc. 2.08% · 1.09M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 30 buys · 18 sells

NameRoleStake
Bruce Caswell Chief Executive Officer 0.63%
Raymond Ruddy Independent Director 0.22%
John Haley Independent Chairperson 0.22%
Richard Montoni Independent Vice Chairperson 0.09%
David Mutryn Chief Financial Officer 0.07%
Anne Altman Independent Vice Chair of the Board 0.06%
Jan Madsen Independent Director 0.04%
Ilene Baylinson General Manager of Health Services U.S. 0.03%
Michael Warren Independent Director 0.03%
Theresa Golinvaux Principal Accounting Officer, Senior VP & Corporate Controller 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-30 Michelle Link Chief Human Resources Officer Automatic Disposition -3,208 $54.23
2026-09-29 Ilene Baylinson General Manager of Health Services U.S. Sale to Issuer -3,944 $53.19
2026-09-29 David Mutryn Chief Financial Officer Sale to Issuer -4,749 $53.19
2026-09-29 Michelle Link Chief Human Resources Officer Sale to Issuer -2,636 $53.19
2026-09-29 Theresa Golinvaux Principal Accounting Officer, Senior VP & Corporate Controller Sale to Issuer -1,243 $53.19
2026-09-29 Elizabeth Moellering General Counsel Sale to Issuer -712 $53.19
2026-04-19 Elizabeth Moellering General Counsel Initial Statement of Beneficial 0 --
2026-03-16 Jan Madsen Independent Director Automatic Disposition -742 $72.25
2026-03-09 John Haley Independent Chairperson Other Acquisition +7,009 --
2026-03-09 Michael Warren Independent Director Other Acquisition +2,246 --
2026-03-09 Jan Madsen Independent Director Other Acquisition +3,215 --
2026-03-09 Anne Altman Independent Vice Chair of the Board Other Acquisition +3,062 --
2026-03-09 Gayathri Rajan Independent Director Other Acquisition +2,246 --
2026-02-26 Richard Montoni Independent Vice Chairperson Other Disposition -7,000 --
2026-02-23 Richard Montoni Independent Vice Chairperson Other Disposition -3,000 --
2026-02-17 John Haley Independent Chairperson Other Acquisition +32,764 --
2026-02-17 John Haley Independent Chairperson Other Disposition -32,764 --
2026-02-09 John Haley Independent Chairperson Other Acquisition +32,764 --
2026-02-09 John Haley Independent Chairperson Other Disposition -32,764 --
2026-02-09 Bruce Caswell Chief Executive Officer Open Market Acquisition +3,175 $76.92–78.77

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-07 20:02:33 · For reference only, not investment advice and not tailored to your situation.